drugset / Trial / NCT02230228
Phase 1 Safety Study of ALK-001 in Healthy Volunteers
NaSingle-groupOpen-labelBasic science
Summary
This protocol is a phase 1 clinical study to assess the safety and pharmacokinetics of ALK-001 in healthy volunteers. Please contact [email protected] for any questions.
Timeline
- Start
- 2014-04
- Primary completion
- 2014-09
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALK-001 | Small molecule | — | Oral |